Skip to main content
Back
Watch Compare

vTv Therapeutics Inc.

Data quality: 100%
VTVT
Nasdaq Manufacturing Chemicals
$36.56
▼ $0.74 (-1.98%)
Mkt Cap: 147.23 M
Price
$37.38
Mkt Cap
147.23 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -25.26 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-73.59%
Below sector avg (-53.53%)
ROIC-46.92%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio9.79
Interest CoverageN/A

Valuation

PE (TTM)
-5.46
Below sector avg (-1.48)
P/B Ratio2.09
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -5.5 -1.5
P/B 2.1 1.6
ROE % -73.6 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

6 analysts
Buy
Current
$36.56
+45.9%
Target
$53.33
$44.00
$52.00
$67.00
Forecast
Forward P/E -9.82
Forward EPS -$3.72
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$3.72
-$6.51 – -$1.83
 0.0 6
FY2026 -$2.57
-$4.79 – -$0.80
 10.00 M 6

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$1.09 -$0.58 +46.7%
Q32025 -$0.98 -$1.08 -10.2%
Q22025 -$0.83 -$0.92 -11.5%
Q12025 -$0.82 -$0.77 +5.5%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -26.97 M
ROE -73.59% ROA -42.84%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -25.26 M
ROIC -46.92% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 9.79
Interest Coverage N/A Asset Turnover 0.00
Working Capital 89.29 M Tangible Book Value 70.54 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.46 Forward P/E N/A
P/B Ratio 2.09 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17.15%
Market Cap 147.23 M Enterprise Value 48.72 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share -6.41 OCF / Share -6.41
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 93.63%
SBC-Adj. FCF -28.86 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 1.02 M 0.0 2.02 M 4.01 M
Net Income -26.97 M -18.46 M -20.25 M -19.16 M -12.99 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -32.81 M -24.18 M -25.50 M -22.54 M -21.66 M
EBITDA — — — — —
R&D Expenses 17.86 M 11.55 M 13.60 M 12.36 M 13.32 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — 0.0 13,000.0 15,000.0 12,000.0
Income Tax 0.0 100,000.0 0.0 200,000.0 115,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 89.90 M 38.27 M 11.02 M 33.24 M 25.47 M
Total Liabilities 25.46 M 23.97 M 29.57 M 27.40 M 10.25 M
Shareholders' Equity 64.44 M 12.20 M -24.68 M -10.74 M -9.74 M
Total Debt — — — — 256,000.0
Cash & Equivalents 88.93 M 36.75 M 9.45 M 12.13 M 13.42 M
Current Assets 89.89 M 38.11 M 10.66 M 27.09 M 15.62 M
Current Liabilities 6.64 M 5.20 M 10.62 M 7.71 M 8.50 M